H
Hannah K. Weir
Researcher at Centers for Disease Control and Prevention
Publications - 96
Citations - 13970
Hannah K. Weir is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 39, co-authored 91 publications receiving 10946 citations. Previous affiliations of Hannah K. Weir include University of Toronto.
Papers
More filters
Journal ArticleDOI
Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
TL;DR: The 5‐year relative survival for prostate cancers diagnosed between 1990 and 1994 in the United States was very high (92%); however, survival in black males was 7% lower compared with white males, and survival by stage and race was examined.
Journal ArticleDOI
Gallbladder Cancer Incidence and Mortality, United States 1999–2011
TL;DR: Data from U.S. population-based cancer registries confirm that gallbladder cancer incidence and death rates are higher among women than men, highest among American Indian and Alaska Native persons, and differ by region.
Journal ArticleDOI
Differences in breast cancer incidence among young women aged 20–49 years by stage and tumor characteristics, age, race, and ethnicity, 2004–2013
TL;DR: Differences in tumor characteristics by age and race/ethnicity suggest opportunities for further research into personal and cultural factors that may influence breast cancer risk among younger women.
Journal ArticleDOI
Breast cancer survival in the US and Europe: a CONCORD high-resolution study
Claudia Allemani,Milena Sant,Hannah K. Weir,Lisa C. Richardson,Paolo Baili,Hans H. Storm,Sabine Siesling,Ana Torrella-Ramos,Adri C. Voogd,Tiiu Aareleid,Eva Ardanaz,Franco Berrino,Magdalena Bielska-Lasota,Susan Bolick,Claudia Cirilli,Marc Colonna,Paolo Contiero,Rosemary D. Cress,Emanuele Crocetti,John P Fulton,Pascale Grosclaude,Timo Hakulinen,M. Isabel Izarzugaza,Per-Uno Malmström,Karin Peignaux,Maja Primic-Žakelj,Jadwiga Rachtan,Chakameh Safaei Diba,María José Sánchez,Maria J. Schymura,Tiefu Shen,Adele Traina,Laufey Tryggvadottir,Rosario Tumino,Michel Velten,Marina Vercelli,Holly J. Wolf,Anne Sophie Woronoff,Xiao-Cheng Wu,Michel P Coleman +39 more
TL;DR: Differences in breast cancer survival between Europe and the US in the late 1990s were mainly explained by lower survival in Eastern Europe, where low healthcare expenditure may have constrained the quality of treatment.
Journal ArticleDOI
Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study
Claudia Allemani,Bernard Rachet,Hannah K. Weir,Lisa C. Richardson,Côme Lepage,Jean Faivre,Gemma Gatta,Riccardo Capocaccia,Milena Sant,Paolo Baili,Claudio Lombardo,Tiiu Aareleid,Eva Ardanaz,Magdalena Bielska-Lasota,Susan Bolick,Rosemary D. Cress,Marloes Elferink,John P Fulton,Jaume Galceran,Stanisław Góźdź,Timo Hakulinen,Maja Primic-Žakelj,Jadwiga Rachtan,Chakameh Safaei Diba,María José Sánchez,Maria J. Schymura,Tiefu Shen,Giovanna Tagliabue,Rosario Tumino,Marina Vercelli,Holly J. Wolf,Xiao-Cheng Wu,Michel P Coleman +32 more
TL;DR: The wide differences in colorectal cancer survival between Europe and the USA in the late 1990s are probably attributable to earlier stage and more extensive use of surgery and adjuvant treatment in the USA.